October 3, 2011
Takeda Pharmaceutical has launched the type 2 diabetes treatment Liovel LD and HD (alogliptin + pioglitazone). The two products combine the dipeptidyl peptidase-4 (DPP-4) inhibitor Nesina (alogliptin) and the thiazolidine Actos (pioglitazone) and are taken once daily. Data released by...read more